Cargando…

Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis

Worldwide prevalence of Huntington’s disease (HD) is quite heterogenous. As Italy is characterized by significant genetic heterogeneity, with presumptive differences between Italian regions, this review was undertaken to define available data of HD prevalence in Italy, to assess geographic heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccò, Matteo, Vezzosi, Luigi, Balzarini, Federica, Gualerzi, Giovanni, Ranzieri, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975892/
https://www.ncbi.nlm.nih.gov/pubmed/32275276
http://dx.doi.org/10.23750/abm.v91i3-S.9441
_version_ 1783666986881908736
author Riccò, Matteo
Vezzosi, Luigi
Balzarini, Federica
Gualerzi, Giovanni
Ranzieri, Silvia
author_facet Riccò, Matteo
Vezzosi, Luigi
Balzarini, Federica
Gualerzi, Giovanni
Ranzieri, Silvia
author_sort Riccò, Matteo
collection PubMed
description Worldwide prevalence of Huntington’s disease (HD) is quite heterogenous. As Italy is characterized by significant genetic heterogeneity, with presumptive differences between Italian regions, this review was undertaken to define available data of HD prevalence in Italy, to assess geographic heterogeneity, and reconcile possible variation in HD prevalence rates with the availability of genetic testing. METHODS. In total, 14 relevant studies were identified from Medline/Embase, and analysis of available Italian regional reports on rare diseases. RESULTS. A cumulative prevalence of 3.9/100,000 inhabitants (95% Confidence Interval 3.0 – 5.0) was identified, with apparently higher rates in the last decades (4.1/100,000 vs. 3.0/100,000). The lowest rates were among the resident of the Oristano province in Sardinia, while the highest were reported in three mountainous and rather isolated areas (i.e. Molise, San Marino, Varese; all well over 10 cases/100,000 inhabitants). These differences cannot be not fully explained by varying approaches to case-ascertainment or diagnosis, and a possible “founder effect” may therefore be extensively advocated. DISCUSSION. The prevalence of HD in retrieved Italian reports varied up to almost tenfold between different geographical regions. Even though such variation can in part be attributed to differences in case-ascertainment and/or diagnostic criteria, there is consistent evidence of significant founder effects in certain areas such as the provinces of Varese, the Republic of San Marino, and the region od Molise – all of them with estimates > 10/100,000 cases. As our estimates suggest that up to half of Italian HD cases may be still waiting, Public Health approach should improve diagnostic rates in order to guaranteeing palliative and symptomatic interventions (antidepressants, antipsychotics, anti-choreiform medications) to all individuals and their families.
format Online
Article
Text
id pubmed-7975892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-79758922021-03-24 Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis Riccò, Matteo Vezzosi, Luigi Balzarini, Federica Gualerzi, Giovanni Ranzieri, Silvia Acta Biomed Original Article Worldwide prevalence of Huntington’s disease (HD) is quite heterogenous. As Italy is characterized by significant genetic heterogeneity, with presumptive differences between Italian regions, this review was undertaken to define available data of HD prevalence in Italy, to assess geographic heterogeneity, and reconcile possible variation in HD prevalence rates with the availability of genetic testing. METHODS. In total, 14 relevant studies were identified from Medline/Embase, and analysis of available Italian regional reports on rare diseases. RESULTS. A cumulative prevalence of 3.9/100,000 inhabitants (95% Confidence Interval 3.0 – 5.0) was identified, with apparently higher rates in the last decades (4.1/100,000 vs. 3.0/100,000). The lowest rates were among the resident of the Oristano province in Sardinia, while the highest were reported in three mountainous and rather isolated areas (i.e. Molise, San Marino, Varese; all well over 10 cases/100,000 inhabitants). These differences cannot be not fully explained by varying approaches to case-ascertainment or diagnosis, and a possible “founder effect” may therefore be extensively advocated. DISCUSSION. The prevalence of HD in retrieved Italian reports varied up to almost tenfold between different geographical regions. Even though such variation can in part be attributed to differences in case-ascertainment and/or diagnostic criteria, there is consistent evidence of significant founder effects in certain areas such as the provinces of Varese, the Republic of San Marino, and the region od Molise – all of them with estimates > 10/100,000 cases. As our estimates suggest that up to half of Italian HD cases may be still waiting, Public Health approach should improve diagnostic rates in order to guaranteeing palliative and symptomatic interventions (antidepressants, antipsychotics, anti-choreiform medications) to all individuals and their families. Mattioli 1885 2020 2020-04-10 /pmc/articles/PMC7975892/ /pubmed/32275276 http://dx.doi.org/10.23750/abm.v91i3-S.9441 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Riccò, Matteo
Vezzosi, Luigi
Balzarini, Federica
Gualerzi, Giovanni
Ranzieri, Silvia
Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title_full Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title_fullStr Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title_full_unstemmed Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title_short Prevalence of Huntington Disease in Italy: a systematic review and meta-analysis
title_sort prevalence of huntington disease in italy: a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975892/
https://www.ncbi.nlm.nih.gov/pubmed/32275276
http://dx.doi.org/10.23750/abm.v91i3-S.9441
work_keys_str_mv AT riccomatteo prevalenceofhuntingtondiseaseinitalyasystematicreviewandmetaanalysis
AT vezzosiluigi prevalenceofhuntingtondiseaseinitalyasystematicreviewandmetaanalysis
AT balzarinifederica prevalenceofhuntingtondiseaseinitalyasystematicreviewandmetaanalysis
AT gualerzigiovanni prevalenceofhuntingtondiseaseinitalyasystematicreviewandmetaanalysis
AT ranzierisilvia prevalenceofhuntingtondiseaseinitalyasystematicreviewandmetaanalysis